Bacterial diversity in cases of lung infection in cystic fibrosis patients: 16S ribosomal DNA (rDNA) length heterogeneity PCR and 16S rDNA terminal restriction fragment length polymorphism profiling

Journal of Clinical Microbiology

Volumn 41, Issue 8, 2003, Pages 3548-3558

  Rogers, G B ^a   Hart, C A ^b   Mason, J R ^a   Hughes, M ^c   Walshaw, M J ^d   Bruce, K D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c LIVERPOOL HEART AND CHEST HOSPITAL   (United Kingdom)

^d Silicon Genetics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA 16S; RIBOSOME RNA;

ADULT; ARTICLE; BACTERIAL DIVERSITY; BACTERIAL FLORA; BRONCHOSCOPY; BURKHOLDERIA CEPACIA; CYSTIC FIBROSIS; DNA DETERMINATION; HAEMOPHILUS INFLUENZAE; HUMAN; LUNG INFECTION; MICROBIAL DIVERSITY; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PATHOGENESIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; SPUTUM ANALYSIS; STENOTROPHOMONAS;

BACTERIAL INFECTIONS; BASE SEQUENCE; BRONCHOSCOPY; CYSTIC FIBROSIS; DNA PRIMERS; DNA, RIBOSOMAL; HUMANS; LUNG DISEASES; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; RNA, RIBOSOMAL, 16S; SPUTUM; VARIATION (GENETICS);

BACTERIA (MICROORGANISMS); BURKHOLDERIA; BURKHOLDERIA CEPACIA; HAEMOPHILUS; HAEMOPHILUS INFLUENZAE; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA; STENOTROPHOMONAS;

EID: 0043025364     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.8.3548-3558.2003     Document Type: Article

References (42)

1. Altschul, S. F., W. Gish, W. Miller, E. W. Myers, and D. J. Lipman. 1990. Basic local alignment search tool. J. Mol. Biol. 215:403-410.
2. Amann, R. I., W. Ludwig, and K. H. Schleifer. 1995. Phylogenetic identification and in situ detection of individual microbial cells without cultivation. Microbiol. Rev. 59:143-169.
3. Ben Dekhil, S. M., M. M. Peel, V. A. Lennox, E. Stackebrandt, and L. I. Sly. 1997. Isolation of Lautropia mirabilis from sputa of a cystic fibrosis patient. J. Clin. Microbiol. 35:1024-1026.
4. Braker, G., H. L. Ayala-Del-Rio, A. H. Devol, A. Fesefeldt, and J. M. Tiedje. 2001. Community structure of denitrifiers, Bacteria, and Archaea along redox gradients in Pacific Northwest marine sediments by terminal restriction fragment length polymorphism analysis of amplified nitrite reductase (nirS) and 16S rRNA genes. Appl. Environ. Microbiol. 67:1893-1901.
5. Brenner, D. J., C. M. O'Hara, P. A. D. Grimont, J. M. Janda, E. Falsen, E. Aldova, E. Ageron, J. Schindler, S. L. Abbott, and A. G. Steigerwalt. 1999. Biochemical identification of Citrobacter species defined by DNA hybridization and description of Citrobacter gillenii sp. nov. (formerly Citrobacter genomospecies 10) and Citrobacter murliniae sp. nov. (formerly Citrobacter genomospecies 11). J. Clin. Microbiol. 37:2619-2624.
6. Bressane, M. A., L. E. Durigon, and M. J. Avila-Campos. 2001. Prevalence of the Bacteroides fragilis group and enterotoxigenic Bacteroides fragilis in immunodeficient children. Anaerobe 7:277-281.
7. Bruce, K. D., and M. R. Hughes. 2000. Terminal restriction fragment length polymorphism monitoring of genes amplified directly from bacterial communities in soils and sediments. Mol. Biotechnol. 16:261-269.
8. Christensen, J. J., and R. R. Facklam. 2001. Granulicatella and Abiotrophia species from human clinical specimens. J. Clin. Microbiol. 39:3520-3523.
9. Costerton, J. W., P. S. Stewart, and E. P. Greenberg. 1999. Bacterial biofilms: a common cause of persistent infections. Science 284:1318-1322.
10. Coenye, T., J. Goris, T. Spilker, P. Vandamme, and J. J. LiPuma. 2002. Characterization of unusual bacteria isolated from respiratory secretions of cystic fibrosis patients and description of Inquilinus limosus gen. nov., sp. nov. J. Clin. Microbiol 40:2062-2069.
11. da Silva Filho, L. V., J. E. Levi, C. N. Oda Bento, S. R. da Silva Ramos, and T. Rozov. 1999. PCR identification of Pseudomonas aeruginosa and direct detection in clinical samples from cystic fibrosis patients. J. Med. Microbiol. 48:357-361.
12. Davis, P. B., M. Drumm, and M. W. Konstan. 1996. Cystic fibrosis. Am. J. Respir. Crit. Care Med. 154:1229-1256.
13. Dunbar, J., L. O. Ticknor, and C. R. Kuske. 2000. Assessment of microbial diversity in four southwestern United States soils by 16S rRNA gene terminal restriction fragment analysis. Appl. Environ. Microbiol. 66:2943-2950.
14. Farrelly, V., F. A. Rainey, and E. Stackebrandt. 1995. Effect of genome size and rrn gene copy number on PCR amplification of 16S rRNA genes from a mixture of mixture of bacterial species. Appl. Environ. Microbiol. 61:2798-2801.
15. Gilljam, H., A. S. Malmborg, and B. Strandvik. 1986. Conformity of bacterial growth in sputum and contamination free endobronchial samples in patients with cystic fibrosis. Thorax 41:641-646.
16. Govan, J. R. W., and V. Deretic. 1996. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 60:539-574.
17. Guieysse, B., P. Wikstrom, M. Forsman, and B. Mattiasson. 2001. Biomonitoring of continuous microbial community adaptation toward more efficient phenol-degradation in a fed-batch bioreactor. Appl. Microbiol. Biotechnol. 56:780-787.
18. Hart, C. A., and C. Winstanley. 2002. Persistent and aggressive bacteria in the lungs of cystic fibrosis children. Br. Med. Bull. 61:81-96.
19. Horz, H. P., M. T. Yimga, and W. Liesack. 2001. Detection of methanotroph diversity on roots of submerged rice plants by molecular retrieval of pmoA, mmoX, mraF, and 16S rRNA and ribosomal DNA, including pmoA-based terminal restriction fragment length polymorphism profiling. Appl. Environ. Microbiol. 67:4177-4185.
20. Hutchison, M. L., and J. R. W. Govan. 1999. Pathogenicity of microbes associated with cystic fibrosis. Microbes Infect. 1:1005-1014.
21. Kaplan, C. W., J. C. Astaire, M. E. Sanders, B. S. Reddy, and C. L. Kitts. 2001. 16S ribosomal DNA terminal restriction fragment pattern analysis of bacterial communities in feces of rats fed Lactobacillus acidophilus NCFM. Appl. Environ. Microbiol. 67:1935-1939.
22. Lewenza, S., M. B. Visser, and P. A. Sokol. 2002. Interspecies communication between Burkholderia cepacia and Pseudomonas aeruginosa. Can. J. Microbiol. 48:707-716.
23. LiPuma, J. J., B. J. Dulaney, J. D. Mmenamin, P. W. Whitby, T. L. Stull, T. Coenye, and P. Vandamme. 1999. Development of rRNA-based PCR assays for identification of Burkholderia cepacia complex isolates recovered from cystic fibrosis patients. J. Clin. Microbiol. 37:3167-3170.
24. Liu, W.-T., T. L. Marsh, H. Cheng, and L. J. Forney. 1997. Characterization of microbial diversity by determining terminal restriction fragment length polymorphisms of genes encoding 16S rRNA. Appl. Environ. Microbiol. 63:4516-4522.
25. Lyczak, J. B., C. L. Cannon, and G. B. Pier. 2002. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15:194-222.
26. Mahenthiralingam, E., A. Baldwin, and P. Vandamme. 2002. Burkholderia cepacia complex infection in patients with cystic fibrosis. J. Med. Microbiol. 51:533-538.
27. Martin, C., M. A. Ichou, P. Massicot, A. Goudeau, and R. Quentin. 1995. Genetic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis revealed by restriction fragment length polymorphism of the rRNA gene region. J. Clin. Microbiol. 33:1461-1466.
28. McDowell, A., E. Mahenthiralingam, J. E. Moore, K. E. A. Dunbar, A. K. Webb, M. E. Dodd, S. L. Martin, B. C. Millar, C. J. Scott, M. Crowe, and J. S. Elborn. 2001. PCR-based detection and identification of Burkholderia cepacia complex pathogens in sputum from cystic fibrosis patients. J. Clin. Microbiol. 39:4247-4255.
29. Murray, A. E., J. T. Hollibaugh, and C. Orrego. 1996. Phylogenetic compositions of bacterioplankton from two California estuaries compared by denaturing gradient gel electrophoresis of 16S rDNA fragments. Appl. Environ. Microbiol. 62:2676-2680.
30. Pitcher, D. G., N. A. Saunders, and R. J. Owen. 1989. Rapid extraction of bacterial genomic DNA with guanidium thiocyanate. Lett. Appl. Microbiol. 8:151-156.
31. Pitulle, C., D. M. Citron, B. Bochner, R. Barbers, and M. D. Appleman. 1999. Novel bacterium isolated from a lung transplant patient with cystic fibrosis. J. Clin. Microbiol. 37:3851-3855.
32. Pryde, S. E., A. J. Richardson, C. S. Stewart, and H. J. Flint. 1999. Molecular analysis of the microbial diversity present in the colonic wall, colonic lumen, and cecal lumen of a pig. Appl. Environ. Microbiol. 65:5372-5377.
33. Ritchie, N. J., M. E. Schutter, R. P. Dick, and D. D. Myrold. 2000. Use of length heterogeneity PCR and fatty acid methyl ester profiles to characterize microbial communities in soil. Appl. Environ. Microbiol. 66:1668-1675.
34. Rosenfeld, M., R. L. Gibson, S. McNamara, J. Emerson, J. L. Burns, R. Castile, P. Hiatt, K. McCoy, C. B. Wilson, A. Inglis, A. Smith, T. R. Martin, and B. W. Ramsey. 2001. Early pulmonary infection, inflammation, and clinical outcomes in infants with cystic fibrosis. Pediatr. Pulm. 32:356-366.
35. Sakai, M., N. Matsunaga, A. Matsuka, and S. Kanazawa. 2001. Application of T-RFLP analysis to the study of bacterial community structure in the rhizosphere. Soil Sci. Plant Nutr. 47:773-778.
36. Suzuki, M., M. S. Rappe, and S. J. Giovannoni. 1998. Kinetic bias in estimates of coastal picoplankton community structure obtained by measurements of small-subunit rRNA gene PCR amplicon length heterogeneity. Appl. Environ. Microbiol. 64:4522-4529.
37. Tümmler, B., and B. C. Kiewitz. 1999. Cystic fibrosis: an inherited susceptibility to bacterial respiratory infections. Mol. Med. Today 5:351-357.
38. van Belkum, A., N. H. Renders, S. Smith, S. E. Overbeek, and H. A. Verbrugh. 2000. Comparison of conventional and molecular methods for the detection of bacterial pathogens in sputum samples from cystic fibrosis patients. FEMS Immunol. Med. Microbiol. 27:51-57.
39. von Wintzingerode, F., U. B. Gobel, and E. Stackebrandt. 1997. Determination of microbial diversity in environmental samples: pitfalls of PCR-based rRNA analysis. FEMS Microbiol. Rev. 21:213-229.
40. Welsh, M. J., L. C. Tsui, T. F. Boat, and A. L. Beaudet. 1995. Cystic fibrosis, p. 3799-3876. In C. R. Sciver, A. L. Beaudet, W. S. Sly, and D. Valle (ed.), The metabolic and molecular bases of inherited disease. McGraw-Hill Professional, New York, N.Y.
41. Whitby, P. W., H. L. N. Dick, P. W. Preston III, D. E. Tullis, A. Matlow, and T. L. Stull. 1998. Comparison of culture and PCR for detection of Burkholderia cepacia in sputum samples of patients with cystic fibrosis. J. Clin. Microbiol. 36:1642-1645.
42. Whitby, P. W., L. C. Pope, K. B. Carter, J. J. LiPuma, and T. L. Stull. 2000. Species-specific PCR as a tool for the identification of Burkholderia gladioli. J. Clin. Microbiol. 38:282-285.